Speakers

David Sourdive

Co-Founder & EVP CMC Manufacturing • Cellectis

David Sourdive, Ph.D., is a co-founder of Cellectis and joined the Board of Directors in 2000.
Dr. Sourdive combines a strong scientific expertise with experience in managing industrial
programs bringing innovative technologies to industrial fruition. He served as Executive Vice
President, Corporate Development, from 2008 to 2016 and as Executive Vice President,
Technical Operations until July 2019. In addition to his role at Cellectis, Dr. Sourdive has also
served on the board of directors of the Mediterranean Institute for Life Sciences. David
Sourdive graduated from École Polytechnique, received his Ph.D. in molecular virology
at Institut Pasteur and completed a research fellowship in the Emory University Department
of Microbiology and Immunology. His management training is from the HEC (Challenge +) and
his decade-long experience in industrial program management was acquired at the
French Department of Defense (DGA) prior to Cellectis’ inception.

Also speaking

Silvio Weber

Director Industrial Workflow Development, Cellular Therapy • Miltenyi Biotec

Neil Dugdale

General Manager UK & Ireland • GenSight Biologics

Mark Trusheim

Strategic Director, NEWDIGS and Visiting Scientist, • Massachusetts Institute of Technology (MIT)

Event Info

Image

2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.
Image

Pub & Pints RSVP

Let us know you’re planning on attending.